CHEMED CORP (CHE) Stock Fundamental Analysis
USA - NYSE:CHE - US16359R1032 - Common Stock
451.33 USD
-6.92 (-1.51%)
CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. CHE gets an excellent profitability rating and is at the same time showing great financial health properties. CHE has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CHE was profitable.
In the past year CHE had a positive cash flow from operations.
In the past 5 years CHE has always been profitable.
In the past 5 years CHE always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 16.90%, CHE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHE has a better Return On Equity (24.23%) than 92.08% of its industry peers.
CHE's Return On Invested Capital of 20.52% is amongst the best of the industry. CHE outperforms 95.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHE is significantly above the industry average of 9.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.9% | ||
| ROE | 24.23% | ||
| ROIC | 20.52% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
1.3 Margins
Looking at the Profit Margin, with a value of 11.56%, CHE belongs to the top of the industry, outperforming 97.03% of the companies in the same industry.
In the last couple of years the Profit Margin of CHE has grown nicely.
CHE has a better Operating Margin (15.49%) than 91.09% of its industry peers.
CHE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 33.65%, CHE is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
In the last couple of years the Gross Margin of CHE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.49% | ||
| PM (TTM) | 11.56% | ||
| GM | 33.65% |
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
Compared to 1 year ago, CHE has less shares outstanding
CHE has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 12.39 indicates that CHE is not in any danger for bankruptcy at the moment.
The Altman-Z score of CHE (12.39) is better than 94.06% of its industry peers.
The Debt to FCF ratio of CHE is 0.00, which is an excellent value as it means it would take CHE, only 0.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CHE (0.00) is better than 94.06% of its industry peers.
CHE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CHE's Debt to Equity ratio of 0.00 is amongst the best of the industry. CHE outperforms 88.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.39 |
ROIC/WACC2.36
WACC8.7%
2.3 Liquidity
CHE has a Current Ratio of 1.86. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.86, CHE is doing good in the industry, outperforming 68.32% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that CHE should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.83, CHE is doing good in the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.97%.
Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 7.55% in the last year.
The Revenue has been growing slightly by 4.63% on average over the past years.
EPS 1Y (TTM)-0.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-21.94%
Revenue 1Y (TTM)7.55%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.85%
3.2 Future
The Earnings Per Share is expected to grow by 5.61% on average over the next years.
Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.12% on average per year.
EPS Next Y-3.48%
EPS Next 2Y4.82%
EPS Next 3Y5.61%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y5.86%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.18, CHE is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 69.31% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. CHE is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.75, CHE is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 65.35% of the companies are valued more expensively.
CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.18 | ||
| Fwd PE | 17.75 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE is on the same level as its industry peers.
CHE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHE is cheaper than 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.71 | ||
| EV/EBITDA | 14.19 |
4.3 Compensation for Growth
The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.9
EPS Next 2Y4.82%
EPS Next 3Y5.61%
5. Dividend
5.1 Amount
CHE has a yearly dividend return of 0.52%, which is pretty low.
CHE's Dividend Yield is rather good when compared to the industry average which is at 2.43. CHE pays more dividend than 80.20% of the companies in the same industry.
With a Dividend Yield of 0.52, CHE pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
On average, the dividend of CHE grows each year by 8.02%, which is quite nice.
CHE has paid a dividend for at least 10 years, which is a reliable track record.
CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
CHE pays out 10.17% of its income as dividend. This is a sustainable payout ratio.
The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP10.17%
EPS Next 2Y4.82%
EPS Next 3Y5.61%
NYSE:CHE (9/19/2025, 12:05:44 PM)
451.33
-6.92 (-1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners96.53%
Inst Owner Change-1.96%
Ins Owners1.59%
Ins Owner Change-4.51%
Market Cap6.58B
Analysts82.5
Price Target590.07 (30.74%)
Short Float %2.87%
Short Ratio2.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP10.17%
Div Incr Years16
Div Non Decr Years21
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.3%
Min EPS beat(2)-15.11%
Max EPS beat(2)0.5%
EPS beat(4)1
Avg EPS beat(4)-4.49%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)3
Avg EPS beat(8)-1.89%
EPS beat(12)5
Avg EPS beat(12)-1.91%
EPS beat(16)9
Avg EPS beat(16)-0.16%
Revenue beat(2)0
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.04%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)1.98%
PT rev (3m)-14.59%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)-13.29%
EPS NY rev (1m)-5.22%
EPS NY rev (3m)-12.53%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-3.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.18 | ||
| Fwd PE | 17.75 | ||
| P/S | 2.62 | ||
| P/FCF | 17.71 | ||
| P/OCF | 15.41 | ||
| P/B | 5.49 | ||
| P/tB | 14.81 | ||
| EV/EBITDA | 14.19 |
EPS(TTM)22.37
EY4.96%
EPS(NY)25.43
Fwd EY5.63%
FCF(TTM)25.49
FCFY5.65%
OCF(TTM)29.29
OCFY6.49%
SpS172.4
BVpS82.26
TBVpS30.48
PEG (NY)N/A
PEG (5Y)1.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.9% | ||
| ROE | 24.23% | ||
| ROCE | 26.76% | ||
| ROIC | 20.52% | ||
| ROICexc | 24.78% | ||
| ROICexgc | 66.31% | ||
| OM | 15.49% | ||
| PM (TTM) | 11.56% | ||
| GM | 33.65% | ||
| FCFM | 14.79% |
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexcg growth 3Y-5.61%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.82% | ||
| Cap/Sales | 2.21% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.24% | ||
| Profit Quality | 127.91% | ||
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 12.39 |
F-Score7
WACC8.7%
ROIC/WACC2.36
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-21.94%
EPS Next Y-3.48%
EPS Next 2Y4.82%
EPS Next 3Y5.61%
EPS Next 5YN/A
Revenue 1Y (TTM)7.55%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.85%
Revenue Next Year5.02%
Revenue Next 2Y5.86%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y-1.51%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year15.45%
EBIT Next 3Y10.26%
EBIT Next 5YN/A
FCF growth 1Y32.69%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y23.7%
OCF growth 3Y10.6%
OCF growth 5Y6.75%